4.7 Article

European Stroke Organization and European Academy Neurology joint guidelines on post-stroke cognitive impairment

Journal

EUROPEAN JOURNAL OF NEUROLOGY
Volume 28, Issue 12, Pages 3883-3920

Publisher

WILEY
DOI: 10.1111/ene.15068

Keywords

cognition; dementia; diagnosis; guidelines; prognosis; stroke

Ask authors/readers for more resources

These guidelines provide evidence-based recommendations on the optimal management of post-stroke cognitive impairment (PSCI), highlighting areas where robust evidence is lacking and suggesting priority areas for future research. Controversies remain in prevention, diagnosis, treatment, and prognosis, indicating a need for further definitive randomized controlled trials.
Background and purpose The optimal management of post-stroke cognitive impairment (PSCI) remains controversial. These joint European Stroke Organization (ESO) and European Academy of Neurology (EAN) guidelines provide evidence-based recommendations to assist clinicians in decision making regarding prevention, diagnosis, treatment and prognosis. Methods Guidelines were developed according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. The working group identified relevant clinical questions, performed systematic reviews, assessed the quality of the available evidence, and made specific recommendations. Expert consensus statements were provided where insufficient evidence was available to provide recommendations. Results There was limited randomized controlled trial (RCT) evidence regarding single or multicomponent interventions to prevent post-stroke cognitive decline. Lifestyle interventions and treating vascular risk factors have many health benefits, but a cognitive effect is not proven. We found no evidence regarding routine cognitive screening following stroke, but recognize the importance of targeted cognitive assessment. We describe the accuracy of various cognitive screening tests, but found no clearly superior approach to testing. There was insufficient evidence to make a recommendation for use of cholinesterase inhibitors, memantine nootropics or cognitive rehabilitation. There was limited evidence on the use of prediction tools for post-stroke cognition. The association between PSCI and acute structural brain imaging features was unclear, although the presence of substantial white matter hyperintensities of presumed vascular origin on brain magnetic resonance imaging may help predict cognitive outcomes. Conclusions These guidelines highlight fundamental areas where robust evidence is lacking. Further definitive RCTs are needed, and we suggest priority areas for future research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available